Paul B. Watkins

Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine*

Kenneth S. Lown, Robert R. Mayo, Alan B. Leichtman et al. · Clinical Pharmacology & Therapeutics · 1997 · 682 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

The human pregnane X receptor: genomic structure and identification and functional characterization of natural allelic variants

Jiong Zhang, Peter Kuehl, E D Green et al. · Pharmacogenetics · 2001 · 290 citations

Life Sciences, Genetics, Molecular Genetics +13

The effect of an individual's cytochrome CYP3A4 activity on docetaxel clearance.

Jo Ann Hirth, Paul B. Watkins, Myla Strawderman et al. · PubMed · 2000 · 202 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

In-vivo phenotyping for CYP3A by a single-point determination of midazolam plasma concentration

Yvonne S. Lin, G. Lockwood, Martin A. Graham et al. · Pharmacogenetics · 2001 · 134 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

The erythromycin breath test selectively measures P450IIIA in patients with severe liver disease

Kenneth S. Lown, Joseph C. Kolars, D. Kim Turgeon et al. · Clinical Pharmacology & Therapeutics · 1992 · 131 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +12